Pharmacokinetics of molsidomine and of its active metabolite, SIN‐1 (or linsidomine), in the elderly
Data up to Jan 2025
Total Citations Per Year
Abstract
References (28)
The Effect of Age on Creatinine Clearance in Men: A Cross-sectional and Longitudinal Study
1976 • 1,111 citations
The effects of age and liver disease on the disposition and elimination of diazepam in adult man.
1975 • 693 citations
Drug Disposition in Old Age
1982 • 589 citations
Antipyrine metabolism in man: Influence of age, alcohol, caffeine, and smoking
1975 • 320 citations
The effect of ageing on the hepatic clearance of propranolol.
1979 • 241 citations
Clinical Pharmacokinetic Considerations in the Elderly
1989 • 178 citations
Effect of age and parenchymal liver disease on the disposition and elimination of chlordiazepoxide (Librium)
1978 • 165 citations
Clinical Pharmacokinetic Considerations in the Elderly
1997 • 136 citations
Effect of aging and cigarette smoking on antipyrine and indocyanine green elimination
1979 • 122 citations
Functional Defects in the Aging Kidney
1972 • 121 citations
Diazepam Kinetics in Relation to Age and Sex
1981 • 109 citations
Absorption and Disposition of Chlordiazepoxide in Young and Elderly Male Volunteers
1977 • 108 citations
Molsidomine in the Treatment of Patients with Angina Pectoris
1980 • 102 citations
Reduced quinidine clearance in elderly persons
1978 • 88 citations
The Effect of Age on the Pharmacokinetics of Diazepam
1980 • 71 citations
Molecular Aspects Underlying the Vasodilator Action of Molsidomine
1989 • 63 citations
Effects of age and chronic renal failure on the urinary excretion kinetics of famotidine in man
1988 • 50 citations
Molecular Aspects Underlying the Vasodilator Action of Molsidomine
1989 • 37 citations
Haemodynamic effects of molsidomin
1978 • 34 citations
Acute double blind trial of a new anti-anginal drug: Molsidomine
1978 • 32 citations
Prevalence of high (3s)-3-hydroxyquinidine/quinidine ratios in serum, and clearance of quinidine in cardiac patients with age
1980 • 27 citations
Hemodynamic effects of molsidomine at rest and during submaximal and maximal exercise in patients with coronary artery disease limited by exertional angina pectoris
1981 • 26 citations
Phenazone (antipyrine) metabolism and distribution in young and elderly adults
1975 • 25 citations
Relaxations to SIN-1, Nitric Oxide, and Sodium Nitroprusside in Canine Arteries and Veins
1989 • 14 citations
Intravenous and oral administration of molsidomine, a pharmacodynamic and pharmacokinetic study
1984 • 10 citations
Determination of the active metabolite of molsidomine in human plasma by reversed-phase high-performance liquid chromatography
1990 • 9 citations
[Human pharmacokinetics of molsidomine].
1983 • 7 citations
Pharmacokinetics of molsidomine and its active metabolite, linsidomine, in patients with liver cirrhosis.
1991 • 7 citations